MedTrace Logo

Spleen-ARFI-assisted-Portal-Hypertension-Evaluation-Study (SAPHES)

NCT03315767 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2017-10-20

No results posted yet for this study

Summary

This study evaluates correlation in changes of HVPG-pressure values and stiffness values (ARFI) for spleen and liver and flow-volume values in Portal vein in patients with liver cirrhosis/Portal Hypertension, respectively, after new-admission of beta-blocker therapy.

Conditions

  • Hypertension, Portal

Interventions

DIAGNOSTIC_TEST

ARFI-elastography and portal vein flow measurement

Liver and spleen-elastography assessed by ARFI-technique and the portal vein flow value-assessment by ultrasound investigation.

DIAGNOSTIC_TEST

HVPG-measurement

Evaluation of Portal Hypertension by HVPG-measurement

Sponsors & Collaborators

  • University of Ulm

    lead OTHER

Principal Investigators

  • Eugen Zizer, MD · University of Ulm

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-10
Primary Completion
2018-08-31
Completion
2018-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03315767 on ClinicalTrials.gov